Login to Your Account



MedImmune Venture Fund: Up To $100M For Biotech

By Randall Osborne


Monday, July 22, 2002
Hard market times did not deter MedImmune Inc. from putting together a venture capital subsidiary that the company said will invest up to $100 million in other biotechnology firms. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription